Association of pan-immune-inflammatory value with metabolic dysfunction-associated steatotic liver disease: findings from NHANES 2017–2020
Lian-Zhen Huang,
No information about this author
Zi-Wei Ni,
No information about this author
Qi Yao
No information about this author
et al.
BMC Gastroenterology,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 3, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
has
become
the
most
common
chronic
worldwide.
The
pan-immune-inflammation
value
(PIV)
been
proposed
as
a
biomarker
for
assessing
immune
status
and
inflammation.
There
is
currently
no
evidence
regarding
effect
of
PIV
on
risk
MASLD.
This
study
aimed
to
investigate
association
between
cross-sectional
included
6462
adults
aged
≥
20
years
from
National
Health
Nutrition
Examination
Survey
2017–2020.
was
calculated
based
blood
count
data.
Weighted
multivariable
logistic
regression
employed
calculate
odds
ratio
(OR)
95%
confidence
interval
(CI)
Restricted
cubic
spline
(RCS)
analysis
conducted
explore
dose-response
relationship
Stratified
sensitivity
analyses
were
performed
confirm
robustness
our
findings.
Among
participants,
2458
diagnosed
with
Positive
associations
LnPIV
MASLD
observed
in
all
three
models
(Model
1:
OR
=
1.46,
CI:
1.28–1.66,
P
<
0.001;
Model
2:
1.41,
1.24–1.60,
3:
1.39,
1.16–1.65,
0.004).
When
classified
into
quartiles,
both
Q3
Q4
exhibited
significantly
increased
risks
compared
reference
Q1
full
adjusted
3
(Q3:
1.63,
1.20–2.22,
0.012;
Q4:
1.76,
1.28–2.41,
0.008;
trend
0.002).
RCS
did
not
show
nonlinear
(P
0.093
nonlinearity).
showed
consistent
positive
subgroups,
supported
reliability
these
results.
Higher
levels
are
associated
an
prevalence
MASLD,
indicating
that
potentially
effective
inflammatory
marker
participants.
Language: Английский
Metabolic Characteristics and Cytokine Gene Polymorphisms as Potential Risk Factors for a Higher Liver Fibrosis Stage in MASLD Patients: A Hospital-Based Study
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3730 - 3730
Published: April 15, 2025
Polymorphisms
in
the
Toll-like
receptor
4
(TLR4)
and
IL-17
cytokine
genes
play
a
role
liver
fibrosis
progression
among
patients
with
MASLD.
The
current
study
aimed
to
investigate
whether
IL17
(A7448G
G197A)
TLR4
(Asp299Gly
Thr399Ile)
gene
polymorphisms
are
associated
increased
stages
MASLD
patients.
Genotyping
for
IL17F-A7488G,
IL17A-G197A,
TLR4-Asp299Gly,
TLR4-Thr399Ile
was
performed
on
sample
of
42
39
healthy
controls.
Serum
levels
IL17F,
IL17A,
were
measured
using
ELISA
techniques.
Bivariate
analysis
revealed
significant
associations
between
glycemic
(p
=
0.006),
lipid
metabolism
(total
cholesterol,
HDL
triglycerides),
severity
<
0.05).
IL17A-G197A
GA
AA
genotypes
more
frequent
advanced
compared
those
without
(GA
genotype
frequency:
42.9%
vs.
7.7%;
14.3%
5.1%;
adjusted
p
0.0423).
In
multivariable
ordinal
logistic
regression,
polymorphism
remained
significantly
higher
(adjusted
0.0155).
Patients
dominant
+
AA)
exhibited
3.91
times
greater
odds
experiencing
at
least
one-stage
increase
GG
OR
3.91,
95%
CI:
1.33–12.34).
This
indicates
that
IL17-related
genetic
metabolic
characteristics
affect
patients,
identified
as
an
independent
multivariate
predictor
progression.
Language: Английский
High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1468 - 1468
Published: Nov. 18, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
recently
introduced
term
for
(SLD).
Although
the
inflammatory
process
central
to
pathogenesis
of
SLD,
research
investigating
differences
in
systemic
inflammation
across
various
SLD
subtypes
as
well
sex
limited.
This
population-based,
cross-sectional
study
investigated
association
between
and
high-sensitivity
C-reactive
protein
(hs-CRP)
levels
among
Korean
adults
(N
=
20,141;
mean
age:
50.8
±
16.7
years).
The
participants
were
classified
into
five
groups
that
included
no
MASLD,
metabolic
alcohol-associated
(MetALD),
alcoholic
with
dysfunction
(ALD
MD),
other
SLDs.
median
(Q1,
Q3)
value
hs-CRP
level
was
0.54
mg/L
(0.33,
1.04).
Among
men,
compared
group,
MetALD,
ALD
MD
associated
41.9%
(95%
confidence
interval
[CI]:
35.1-49.1%),
46.8%
CI:
35.0-59.6%),
51.8%
30.0-77.2%)
increases
levels,
respectively.
stronger
women,
81.5%
73.6-89.8%),
84.3%
58.1-114.8%),
98.2%
38.0-184.8%)
In
conclusion,
our
findings
indicate
varying
profile
subtypes,
more
pronounced
women
Language: Английский